CHMP meeting highlights – January 2023
30 January 2023 | By Catherine Eckford (European Pharmaceutical Review)
Four new medicines were recommended for approval at the Committee for Medicinal Products for Human Use (CHMP)’s January meeting, with positive opinions given to two type 2 diabetes drugs.